Drugs that contain Esomeprazole Magnesium; Naproxen
1. List of Vimovo drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8858996 | HORIZON | Pharmaceutical compositions for the coordinated delivery of NSAIDS |
May, 2022
(7 months ago) | |
| US8852636 | HORIZON | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
May, 2022
(7 months ago) | |
| US9161920 | HORIZON | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
May, 2022
(7 months ago) | |
| US9198888 | HORIZON | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
May, 2022
(7 months ago) | |
| US9707181 | HORIZON | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
May, 2022
(7 months ago) | |
| US9345695 | HORIZON | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
May, 2022
(7 months ago) | |
| US9393208 | HORIZON | Method for delivering a pharmaceutical composition to patient in need thereof |
Sep, 2029
(6 years from now) | |
| US9220698 | HORIZON | Method for delivering a pharmaceutical composition to patient in need thereof |
Mar, 2031
(8 years from now) | |
| US8945621 | HORIZON | Method for treating a patient at risk for developing an NSAID-associated ulcer |
Oct, 2031
(8 years from now) | |
Market Authorisation Date: 30 April, 2010
Treatment: Relief of signs and symptoms of arthritis and risk-reduction of nsaid-associated gastric ulcer; Risk-reduction of nsaid gastric ulcer in patients requiring chronic nsaid treatment; Risk-reduction of nsaid-associated gastric ulcer in patients requiring nsaid treatment; Risk-reduction of nsaid-associated gastric ulcers in patients also taking low dose aspirin
Dosage: TABLET, DELAYED RELEASE;ORAL
availability in other generic markets.
Click on the highlighted region to filter.
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic